ZBiotics raised $12M in a Series A funding round led by Spring Tide Capital to expand retail operations and further research in genetically engineered probiotics.
ZBiotics raised $12M in a Series A funding round led by Spring Tide Capital to expand retail operations and further research in genetically engineered probiotics.
08/27/24, 1:21 PM
Location
san franciscoMoney raised
$12 million
Industry
biotechnology
health care
Round Type
series a
Investors
Seaside Ventures, Goat Rodeo Capital, Seamless Capital, Access Capital, Spring Tide Capital
ZBiotics has closed a $12M Series A funding round, which will support its growth in consumer demand and product development. The round was led by Spring Tide Capital and included participation from several other investors.
Company Info
Location
san francisco, california, united states
Additional Info
ZBiotics is the world's first maker of genetically engineered probiotics, purpose-built to improve our health by addressing modern biological challenges. Founded by a team of Ph.D. scientists, the company creates genetically engineered probiotics for specific use cases. Their flagship product, the Pre-Alcohol Probiotic Drink, mimics liver function to break down alcohol toxins. ZBiotics is committed to transparency and offers sustainable, effective solutions through modern biotechnology.